ALPHYN BIOLOGICS
Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases. Alphyn's initial target indication are skin infections caused by deadly drug-resistant MRSA bacteria based on their proprietary Multi-Target Therapeutic (MTT) plant-derived technology platform.
ALPHYN BIOLOGICS
Social Links:
Industry:
Health Care Life Science Pharmaceutical Therapeutics
Founded:
2019-01-01
Address:
Cincinnati, Ohio, United States
Country:
United States
Website Url:
http://www.alphynbiologics.com
Total Employee:
1+
Status:
Active
Contact:
+(443) 994-0101
Total Funding:
11.83 M USD
Technology used in webpage:
Person Schema Gravatar Profiles U.S. Server Location
Similar Organizations
Aviceda Therapeutics
Aviceda Therapeutics is a late-stage, pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Flightpath Biosciences
Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.
Quick-Med Technologies
This company is a life sciences company focused on developing proprietary, broad-based technologies.
Theragene Pharmaceuticals
Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases.
Current Employees Featured
Founder
Investors List
Serial Stage Venture Partners
Serial Stage Venture Partners investment in Series A - Alphyn Biologics
Queen City Angels
Queen City Angels investment in Series A - Alphyn Biologics
Angel Physicians Fund
Angel Physicians Fund investment in Series A - Alphyn Biologics
Official Site Inspections
http://www.alphynbiologics.com Semrush global rank: 16.35 M Semrush visits lastest month: 1
- Host name: cloudproxy10175.sucuri.net
- IP address: 192.124.249.175
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Alphyn Biologics"
About - Alphyn
He was the co-founder and CEO of Symbio, growing the company into a major U.S. and European Clinical Research Organization (CRO). At Symbio, he was responsible for running numerous dermatology drug clinical trials and โฆSee details»
Alphyn Biologics - Crunchbase Company Profile & Funding
Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases.See details»
Alphyn Biologics, Inc. | LinkedIn
Alphyn Biologics is a clinical-stage dermatology company developing first-in-class multi-target therapeutics for severe and prevalent skin diseases based on its AB-101 platform. Its lead โฆSee details»
Alphyn Biologics Company Profile - Office Locations ... - Craft
Alphyn Biologics has 5 employees across 4 locations and $5.47 m in total funding,. See insights on Alphyn Biologics including office locations, competitors, revenue, financials, executives, โฆSee details»
ALPHYN BIOLOGICS, LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ALPHYN BIOLOGICS, LLC of Annapolis, MD. Get the latest business insights from Dun & Bradstreet.See details»
Alphyn Biologics - CEO and Investor Conference 2025
Feb 10, 2025 Alphyn is developing first-in-class therapeutics for severe and prevalent skin diseases using its unique multiple bioactive Zabalafin Multi-Target Therapeutic Drug Platform. โฆSee details»
Alphyn Biologics LLC - Drug pipelines, Patents, Clinical trials
May 7, 2025 Explore Alphyn Biologics LLC with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 18 news, Disease Domain:Neoplasms, Immune System ...See details»
Home - Alphyn
ALPHYN BIOLOGICS is developing breakthrough therapies to treat the worldโs most challenging, severe, and common skin diseases. We are dedicated to improving the lives of millions of โฆSee details»
Alphyn Biologics, Inc. - Org Chart, Teams, Culture & Jobs | The Org
View Alphyn Biologics, Inc.'s up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Alphyn Biologics - Overview, News & Similar companies - ZoomInfo
View Alphyn Biologics (www.alphynbiologics.com) location in Maryland, United States , revenue, industry and description. Find related and similar companies as well as employees by title and โฆSee details»
Alphyn Biologics Inc. - BioCentury Company Profiles - BCIQ
REQUEST A FREE TRIAL Overview Pipeline Deals Financings Articles Alphyn Biologics Inc. Headquarters: Cincinnati, OH Website: https://alphynbiologics.com Year Founded: 2019 โฆSee details»
Alphyn Biologics - LifeScienceHistory.com
Alphyn Biologics is a life science company creating a new class of drugs, Multi-Target Therapeutics๏พ, for more powerful and effective therapies.See details»
Alphyn Biologics - VentureRadar
"Alphyn is developing proprietary drug treatments for serious skin diseases such as infected and non-infected atopic dermatitis (AD) and Epidermolysis Bullosa (EB), a pediatric Orphan Drug โฆSee details»
Contact - Alphyn
BREAKTHROUGH THERAPIES FOR SKIN DISEASESTM Alphyn Biologics is a life science company creating a new class of drugs, Multi-Target Therapeutics ® (MTT โข), for more โฆSee details»
Pipeline - Alphyn
We are advancing the first Multi-Target Therapeutics ® (MTT โข) based on our Zabalafin Platform (AB-101 Platform) to treat and cure severe and common skin diseases. Alphynโs Platform โฆSee details»
Alphyn Biologics - BIO International Convention | BIO
Jun 5, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.See details»
Alphyn Biologics - VentureRadar
Arcutis Biotherapeutics USA Listed Arcutis is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated โฆSee details»
Platform - Alphyn
Alphynโs Zabalafin Platform (AB-101 Platform) is a single source botanical with multiple bioactive compounds to produce therapeutics with multiple mechanisms of action. This enables โฆSee details»
Alphyn Announces Positive Results from Second Cohort of Phase โฆ
ANNAPOLIS, Md., March 7, 2024 /PRNewswire/ โ Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics ®, announced today that the second cohort โฆSee details»
Alphyn Announces First Patient Dosed in CLEAR-AD1 Global Phase โฆ
ANNAPOLIS, Md., April 8, 2025 /PRNewswire/ โ Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics ®, announced today that the first patient โฆSee details»